Blog Daily Mail: Suppliers of vaccine materials do not have capacity November 15, 2020 GreenLight CEO, Andrey Zarur, has been quoted in the Daily Mail about supply chain issues relating to vaccine materials for Covid-19. Credit: Anadolu Agency via Getty Images Andrey Zarur, chief executive of GreenLight Biosciences, has been quoted in the Daily Mail about the capacity issues of suppliers of vaccine materials. He said: ‘The supply chain is just not mature enough. They have existed for laboratory-scale processes, which need nanograms, but they have to go from nanogram scale, to kilogram scale,’ he added. Read the full articles:November 14, 2020: British drugs giant Glaxo has already made millions of doses of ANOTHER vaccine – raising hopes of it being made available early next yearNovember 15, 2020:‘We ARE seeing a slow down in the rate of growth’: Office for National Statistics confirms ‘good news’ as UK records 168 new Covid deaths and 24,962 cases – up 21% on last weekNovember 16, 2020:Civil servants have ‘serious doubts’ over Covid safety in Government as 10 Tory MPs join Boris Johnson in self-isolation after one tested positiveFind out more about how GreenLight manufactures RNA. More of GreenLight Biosciences in the news: STAT: Businesses across the vaccine supply chain must work together to make Covid-19 vaccines Financial Times: Get vaccine new variant ready Mail Online: Vaccine roll out issues Financial Times: Vaccine makers race to fix vaccine supply issues Technology Review: What are the Pfizer covid-19 vaccine ingredients? Financial Times: Vaccine manufacturing delays leave UK with fewer vaccines than hoped